Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Healius Limited ( (AU:HLS) ).
Healius Limited has applied to the ASX for quotation of 22,978 new ordinary fully paid shares, with an issue date of 23 April 2026. The additional securities arise from the exercise or conversion of existing options or other convertible instruments, modestly increasing the company’s listed share capital and reflecting ongoing employee or investor equity participation mechanisms.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.81 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is an Australian-listed healthcare company operating under the ASX code HLS. It provides medical and health-related services, with its ordinary fully paid shares traded on the Australian Securities Exchange as part of the local healthcare sector.
Average Trading Volume: 3,440,235
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$374M
For detailed information about HLS stock, go to TipRanks’ Stock Analysis page.